There are currently no less than 5 prescription medications available for IOP disorder , the most commonly prescribed would be Xalatan . if Skye got SBI-100 all the way through FDA approval , Why would this product be superior ? and ....thus prescribed more so than the widely known Xalatan ? what kind of market share $$$ are we talking to re-invent the wheel ? TIA.....